当前位置: X-MOL 学术Clin. Exp. Allergy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Further considerations for venom immunotherapy following the withdrawal of Pharmalgen
Clinical & Experimental Allergy ( IF 6.3 ) Pub Date : 2020-07-13 , DOI: 10.1111/cea.13690
Mich Erlewyn-Lajeunesse 1, 2 , Cherry Alviani 1, 2 , Stephanie Cross 1, 2 , Emma Grainger-Allen 1
Affiliation  

Ultrarush protocols induce tolerance over two to three day hospital admission. They are useful when protection is required as a matter of urgency, or there are circumstances that would preclude conventional weekly visits for up dosing.

中文翻译:

Pharmalgen 退出后对毒液免疫治疗的进一步考虑

Ultrarush 协议在住院两到三天内诱导耐受。当紧急需要保护时,或者在某些情况下会排除常规的每周访问以增加剂量时,它们很有用。
更新日期:2020-07-13
down
wechat
bug